An improved understanding of non-alcoholic fatty liver disease epidemiology would lead to
identification of individuals at high risk of developing chronic liver disease and extra-hepatic …

Aliment Pharmacol Ther 2011; 34: 274–285 Summary Background Non‐alcoholic fatty liver
disease (NAFLD) is a common cause of chronic liver disease, and its worldwide prevalence …

Metabolic associated fatty liver disease (MAFLD) is the principal worldwide cause of liver
disease and affects nearly a quarter of the global population. The objective of this work was …

Non‐alcoholic fatty liver disease (NAFLD) has a rapidly rising prevalence worldwide and is
the most common cause of liver disease in developed countries. In this article, we discuss …

Diseases of the gallbladder are common and costly. The best epidemiological screening
method to accurately determine point prevalence of gallstone disease is ultrasonography …

Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of hepatic
histopathological changes ranging from non-inflammatory intracellular fat deposition to non …

Gallstone disease is a major health problem that is escalating. To identify risk factors in a
given population, epidemiologic studies must first define the frequency of disease. Such …

Gallstone disease (GD) is a chronic recurrent hepatobiliary disease, the basis for which is
the impaired metabolism of cholesterol, bilirubin and bile acids, which is characterized by …

Nonalcoholic fatty liver disease (NAFLD) is an increasingly recognized cause of liver-related
morbidity and mortality. It can develop secondary to numerous causes but a great majority of …

OBJECTIVES: Other than weight-related conditions, risk factors for non-alcoholic fatty liver
disease (NAFLD) are not well defined. We investigated the association of gallstones and …